An integrated bioinformatics and computational biology approach identifies new BH3-only protein candidates

Open Biology Journal

Volumn 5, Issue , 2012, Pages 6-16

  Hawley, Robert G ^a   Chen, Yuzhong ^a,b   Riz, Irene ^a   Zeng, Chen ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b Arizona State University   (United States)

Author keywords

Apoptosis; Autophagy; DNA damage checkpoint

Indexed keywords

EID: 84874821626     PISSN: None     EISSN: 18741967     Source Type: Journal    
DOI: 10.2174/1874196701205010006     Document Type: Article

References (100)

1. Shamas-Din A, Brahmbhatt H, Leber B, Andrews DW. BH3-only proteins: Orchestrators of apoptosis. Biochim Biophys Acta 2011; 1813: 508-20.
2. Elkholi R, Floros KV, Chipuk JE. The role of BH3-only proteins in tumor cell development, signaling, and treatment. Genes Cancer 2011; 2: 523-37.
3. Sattler M, Liang H, Nettesheim D, et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 1997; 275: 983-6.
4. Petros AM, Nettesheim DG, Wang Y, et al. Rationale for BclxL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci 2000; 9: 2528-34.
5. Lama D, Sankararamakrishnan R. Molecular dynamics simulations of pro-Apoptotic BH3 peptide helices in aqueous medium: relationship between helix stability and their binding affinities to the anti-Apoptotic protein Bcl-X(L). J Comput Aided Mol Des 2011; 25: 413-26.
6. Day CL, Smits C, Fan FC, Lee EF, Fairlie WD, Hinds MG. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1. J Mol Biol 2008; 380: 958-71.
7. Lanave C, Santamaria M, Saccone C. Comparative genomics: the evolutionary history of the Bcl-2 family. Gene 2004; 333: 71-9.
8. Hinds MG, Day CL. Regulation of apoptosis: uncovering the binding determinants. Curr Opin Struct Biol 2005; 15: 690-9.
9. Chen L, Willis SN, Wei A, et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005; 17: 393-403.
10. Certo M, Del GMV, Nishino M, et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 2006; 9: 351-65.
11. Dutta S, Gulla S, Chen TS, Fire E, Grant RA, Keating AE. Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL. J Mol Biol 2010; 398: 747-62.
12. Lee EF, Czabotar PE, Smith BJ, et al. Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family. Cell Death Differ 2007; 14: 1711-3.
13. Boersma MD, Sadowsky JD, Tomita YA, Gellman SH. Hydrophile scanning as a complement to alanine scanning for exploring and manipulating protein-protein recognition: application to the Bim BH3 domain. Protein Sci 2008; 17: 1232-40.
14. Sabourin LA, Hawley RG. Suppression of programmed death and G1 arrest in B-cell hybridomas by interleukin-6 is not accompanied by altered expression of immediate early response genes. J Cell Physiol 1990; 145: 564-74.
15. Schwarze MMK, Hawley RG. Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin-6-mediated upregulation of bcl-xL. Cancer Res 1995; 55: 2262-5.
16. Haughn L, Hawley RG, Morrison DK, von BH, Hockenbery DM. BCL-2 and BCL-XL restrict lineage choice during hematopoietic differentiation. J Biol Chem 2003; 278: 25158-65.
17. Yang Z, Gagarin D, Ramezani A, Hawley RG, McCaffrey TA. Resistance to fas-induced apoptosis in cells from human atherosclerotic lesions: elevated Bcl-XL inhibits apoptosis and caspase activation. J Vasc Res 2007; 44: 483-94.
18. Riz I, Zweier-Renn LA, Toma I, Hawley TS, Hawley RG. Apoptotic role of IKK in T-ALL therapeutic response. Mol Cancer Res 2011; 9: 979-84.
19. Aurora R, Rose GD. Helix capping. Protein Sci 1998; 7: 21-38.
20. Rost B, Yachdav G, Liu J. The PredictProtein server. Nucleic Acids Res 2004; 32: 321-6.
21. Chen H, Van Duyne R, Zhang N, Kashanchi F, Zeng C. A novel binding pocket of cyclin-dependent kinase 2. Proteins 2009; 74: 122-32.
22. van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ. GROMACS: fast, flexible, and free. J Comput Chem 2005; 26: 1701-18.
23. Xiang Z, Honig B. Extending the accuracy limits of prediction for side-chain conformations. J Mol Biol 2001; 311: 421-30.
24. Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. LINCS: a linear constraint solver for molecular simulations. J Comput Chem 1997; 18: 1463-72.
25. Berendsen HJC, Postma JPM, van Gunsteren WF, Dinola A, Haak Jr. Molecular-dynamics with coupling to an external bath. J Chem Phys 1984; 81: 3684-90.
26. Chau BN, Cheng EH, Kerr DA, Hardwick JM. Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1. Mol Cell 2000; 6: 31-40.
27. Kutuk O, Temel SG, Tolunay S, Basaga H. Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL. Eur J Cancer 2010; 46: 2494-505.
28. Bratton SB, Salvesen GS. Regulation of the Apaf-1-caspase-9 apoptosome. J Cell Sci 2010; 123: 3209-14.
29. Aouacheria A, Brunet F, Gouy M. Phylogenomics of life-or-death switches in multicellular animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators. Mol Biol Evol 2005; 22: 2395-416.
30. Chinnadurai G, Vijayalingam S, Rashmi R. BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene 2008; 27 (Suppl. 1): S20-9.
31. Guo B, Godzik A, Reed JC. Bcl-G, a novel pro-Apoptotic member of the Bcl-2 family. J Biol Chem 2001; 276: 2780-5.
32. Moroy G, Martin E, Dejaegere A, Stote RH. Molecular basis for Bcl-2 homology 3 domain recognition in the Bcl-2 protein family: identification of conserved hot spot interactions. J Biol Chem 2009; 284: 17499-511.
33. Ding J, Zhang Z, Roberts GJ, et al. Bcl-2 and Bax interact via the BH1-3 groove-BH3 motif interface and a novel interface involving the BH4 motif. J Biol Chem 2010; 285: 28749-63.
34. Zou S, Chang J, LaFever L, et al. Identification of dAven, a Drosophila melanogaster ortholog of the cell cycle regulator Aven. Cell Cycle 2011; 10: 989-98.
35. Lama D, Sankararamakrishnan R. Anti-Apoptotic Bcl-XL protein in complex with BH3 peptides of pro-Apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations. Proteins 2008; 73: 492-514.
36. Guo JY, Yamada A, Kajino T, et al. Aven-dependent activation of ATM following DNA damage. Curr Biol 2008; 18: 933-42.
37. Gross A. A new Aven-ue to DNA-damage checkpoints. Trends Biochem Sci 2008; 33: 514-6.
38. Komatsu K, Miyashita T, Hang H, et al. Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis. Nat Cell Biol 2000; 2: 1-6.
39. Lee MW, Hirai I, Wang HG. Caspase-3-mediated cleavage of Rad9 during apoptosis. Oncogene 2003; 22: 6340-6.
40. Meyerkord CL, Takahashi Y, Araya R, Takada N, Weiss RS, Wang HG. Loss of Hus1 sensitizes cells to etoposide-induced apoptosis by regulating BH3-only proteins. Oncogene 2008; 27: 7248-59.
41. Zinkel SS, Hurov KE, Ong C, Abtahi FM, Gross A, Korsmeyer SJ. A role for proapoptotic BID in the DNA-damage response. Cell 2005; 122: 579-91.
42. Kamer I, Sarig R, Zaltsman Y, et al. Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 2005; 122: 593-603.
43. Doerks T, Strauss M, Brendel M, Bork P. GRAM, a novel domain in glucosyltransferases, myotubularins and other putative membrane-Associated proteins. Trends Biochem Sci 2000; 25: 483-5.
44. Stanelle J, Tu-Rapp H, Putzer BM. A novel mitochondrial protein DIP mediates E2F1-induced apoptosis independently of p53. Cell Death Differ 2005; 12: 347-57.
45. John K, Alla V, Meier C, Putzer BM. GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria. Cell Death Differ 2011; 18: 874-86.
46. Hinds MG, Smits C, Fredericks-Short R, et al. Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets. Cell Death Differ 2007; 14: 128-36.
47. Gottfried I, Ehrlich M, Ashery U. The Sla2p/HIP1/HIP1R family: similar structure, similar function in endocytosis? Biochem Soc Trans 2010; 38: 187-91.
48. Wanker EE, Rovira C, Scherzinger E, et al. HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system. Hum Mol Genet 1997; 6: 487-95.
49. Kalchman MA, Koide HB, McCutcheon K, et al. HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membraneassociated huntingtin in the brain. Nat Genet 1997; 16: 44-53.
50. Seki N, Muramatsu M, Sugano S, et al. Cloning, expression analysis, and chromosomal localization of HIP1R, an isolog of huntingtin interacting protein (HIP1). J Hum Genet 1998; 43: 268-71.
51. Engqvist-Goldstein AE, Kessels MM, Chopra VS, Hayden MR, Drubin DG. An actin-binding protein of the Sla2/Huntingtin interacting protein 1 family is a novel component of clathrin-coated pits and vesicles. J Cell Biol 1999; 147: 1503-18.
52. Hyun TS, Rao DS, Saint-Dic D, et al. HIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin Nterminal homology domains. J Biol Chem 2004; 279: 14294-306.
53. Brett TJ, Legendre-Guillemin V, McPherson PS, Fremont DH. Structural definition of the F-Actin-binding THATCH domain from HIP1R. Nat Struct Mol Biol 2006; 13: 121-30.
54. Chopra VS, Metzler M, Rasper DM, et al. HIP12 is a nonproapoptotic member of a gene family including HIP1, an interacting protein with huntingtin. Mamm Genome 2000; 11: 1006-15.
55. Rao DS, Bradley SV, Kumar PD, et al. Altered receptor trafficking in Huntingtin Interacting Protein 1-Transformed cells. Cancer Cell 2003; 3: 471-82.
56. Itoh T, Koshiba S, Kigawa T, Kikuchi A, Yokoyama S, Takenawa T. Role of the ENTH domain in phosphatidylinositol-4,5-bisphosphate binding and endocytosis. Science 2001; 291: 1047-51.
57. Hackam AS, Yassa AS, Singaraja R, et al. Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain. J Biol Chem 2000; 275: 41299-308.
58. Gervais FG, Singaraja R, Xanthoudakis S, et al. Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat Cell Biol 2002; 4: 95-105.
59. Rao DS, Hyun TS, Kumar PD, et al. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. J Clin Invest 2002; 110: 351-60.
60. Rao DS, Chang JC, Kumar PD, et al. Huntingtin interacting protein 1 Is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors. Mol Cell Biol 2001; 21: 7796-806.
61. Kim JH, Yoon S, Won M, et al. HIP1R interacts with a member of Bcl-2 family, BCL2L10, and induces BAK-dependent cell death. Cell Physiol Biochem 2009; 23: 43-52.
62. Ke H, Parron VI, Reece J, Zhang JY, Akiyama SK, French JE. BCL2 inhibits cell adhesion, spreading, and motility by enhancing actin polymerization. Cell Res 2010; 20: 458-69.
63. Ke H, Zhang JY, Akiyama SK, French JE. BCL2 interaction with actin in vitro may inhibit cell motility by enhancing actin polymerization. Cell Adh Migr 2011; 5: 6-10.
64. Navarro-Lerida I, Martinez MM, Roncal F, Gavilanes F, Albar JP, Rodriguez-Crespo I. Proteomic identification of brain proteins that interact with dynein light chain LC8. Proteomics 2004; 4: 339-46.
65. Puthalakath H, Huang DC, O'Reilly LA, King SM, Strasser A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 1999; 3: 287-96.
66. Day CL, Puthalakath H, Skea G, et al. Localization of dynein light chains 1 and 2 and their pro-Apoptotic ligands. Biochem J 2004; 377: 597-605.
67. Rapali P, Szenes A, Radnai L, Bakos A, Pal G, Nyitray L. DYNLL/LC8: a light chain subunit of the dynein motor complex and beyond. FEBS J 2011; 278: 2980-96.
68. Steeg PS, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988; 80: 200-4.
69. Wallet V, Mutzel R, Troll H, et al. Dictyostelium nucleoside diphosphate kinase highly homologous to Nm23 and Awd proteins involved in mammalian tumor metastasis and Drosophila development. J Natl Cancer Inst 1990; 82: 1199-202.
70. Boissan M, Dabernat S, Peuchant E, Schlattner U, Lascu I, Lacombe ML. The mammalian Nm23/NDPK family: from metastasis control to cilia movement. Mol Cell Biochem 2009; 329: 51-62.
71. Desvignes T, Pontarotti P, Bobe J. Nme gene family evolutionary history reveals pre-metazoan origins and high conservation between humans and the sea anemone, Nematostella vectensis. PLoS One 2010; 5: e15506.
72. Venturelli D, Martinez R, Melotti P, et al. Overexpression of DRnm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells. Proc Natl Acad Sci USA 1995; 92: 7435-9.
73. Negroni A, Venturelli D, Tanno B, et al. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis. Cell Death Differ 2000; 7: 843-50.
74. Kang Y, Lee DC, Han J, et al. NM23-H2 involves in negative regulation of Diva and Bcl2L10 in apoptosis signaling. Biochem Biophys Res Commun 2007; 359: 76-82.
75. Song Q, Kuang Y, Dixit VM, Vincenz C. Boo, a novel negative regulator of cell death, interacts with Apaf-1. EMBO J 1999; 18: 167-78.
76. Lee R, Chen J, Matthews CP, McDougall JK, Neiman PE. Characterization of NR13-related human cell death regulator, Boo/Diva, in normal and cancer tissues. Biochim Biophys Acta 2001; 1520: 187-94.
77. Venturelli D, Cesi V, Ransac S, Engelhard A, Perrotti D, Calabretta B. The nucleoside diphosphate kinase activity of DRnm23 is not required for inhibition of differentiation and induction of apoptosis in 32Dcl3 myeloid precursor cells. Exp Cell Res 2000; 257: 265-71.
78. Thompson DA, Weigel RJ. Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas. Eur J Biochem 1998; 252: 169-77.
79. Van Laer L, Huizing EH, Verstreken M, et al. Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet 1998; 20: 194-7.
80. Akino K, Toyota M, Suzuki H, et al. Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer. Cancer Sci 2007; 98: 88-95.
81. Kim MS, Chang X, Yamashita K, et al. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma. Oncogene 2008; 27: 3624-34.
82. Kim MS, Lebron C, Nagpal JK, et al. Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer. Biochem Biophys Res Commun 2008; 370: 38-43.
83. Lage H, Helmbach H, Grottke C, Dietel M, Schadendorf D. DFNA5 (ICERE-1) contributes to acquired etoposide resistance in melanoma cells. FEBS Lett 2001; 494: 54-9.
84. Masuda Y, Futamura M, Kamino H, et al. The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage. J Hum Genet 2006; 51: 652-64.
85. Webb MS, Miller AL, Thompson EB. In CEM cells the autosomal deafness gene dfna5 is regulated by glucocorticoids and forskolin. J Steroid Biochem Mol Biol 2007; 107: 15-21.
86. Park HJ, Cho HJ, Baek JI, et al. Evidence for a founder mutation causing DFNA5 hearing loss in East Asians. J Hum Genet 2010; 55: 59-62.
87. Van Laer L, Vrijens K, Thys S, et al. DFNA5: hearing impairment exon instead of hearing impairment gene? J Med Genet 2004; 41: 401-6.
88. Op de Beeck K, Van Camp G, Thys S, et al. The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein. Eur J Hum Genet 2011; 19: 965-73.
89. Zhang J, Ney PA. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ 2009; 16: 939-46.
90. Tan KO, Tan KM, Chan SL, et al. MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains. J Biol Chem 2001; 276: 2802-7.
91. Mund T, Gewies A, Schoenfeld N, Bauer MK, Grimm S. Spike, a novel BH3-only protein, regulates apoptosis at the endoplasmic reticulum. FASEB J 2003; 17: 696-8.
92. Broustas CG, Gokhale PC, Rahman A, Dritschilo A, Ahmad I, Kasid U. BRCC2, a novel BH3-like domain-containing protein, induces apoptosis in a caspase-dependent manner. J Biol Chem 2004; 279: 26780-8.
93. Rodolfo C, Mormone E, Matarrese P, et al. Tissue transglutaminase is a multifunctional BH3-only protein. J Biol Chem 2004; 279: 54783-92.
94. Liu Z, Lu H, Jiang Z, Pastuszyn A, Hu CA. Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells. Mol Cancer Res 2005; 3: 21-31.
95. Wan G, Zhaorigetu S, Liu Z, Kaini R, Jiang Z, Hu CA. Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipidbinding protein, induces autophagic cell death. J Biol Chem 2008; 283: 21540-9.
96. Szigeti A, Hocsak E, Rapolti E, et al. Facilitation of mitochondrial outer and inner membrane permeabilization and cell death in oxidative stress by a novel Bcl-2 homology 3 domain protein. J Biol Chem 2010; 285: 2140-51.
97. Behrends C, Sowa ME, Gygi SP, Harper JW. Network organization of the human autophagy system. Nature 2010; 466: 68-76.
98. Danial NN, Gimenez-Cassina A, Tondera D. Homeostatic functions of BCL-2 proteins beyond apoptosis. Adv Exp Med Biol 2010; 687: 1-32.
99. Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 2011; 13: 184-90.
100. Rubinstein AD, Eisenstein M, Ber Y, Bialik S, Kimchi A. The autophagy protein Atg12 associates with antiapoptotic Bcl-2 family members to promote mitochondrial apoptosis. Mol Cell 2011; 44: 698-709.